TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: IPF exacerbation/progression
Endpoint domain: Adverse events/effects
Primary endpoint: NIH-CPSI pain-domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of visceral fat area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase of adiponectin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of intrapartum fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS values during labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical remission at week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endoscopic response at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-vaccination GMC (Geometric Mean Concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity for LVH diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: antisocial behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICU-acquired Pa infections
Endpoint domain: Adverse events/effects
Primary endpoint: Mean proportion of participant-days achieving the goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Attachment Inventory total scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: prevalence of residual complaints
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of IL-1ra and IL-1 beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Postoperative glare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom Checklist‐90 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: learner knowledge and confidence in palliative care skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Menstrual dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Pain and distension scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CSA at T2 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MACE or MALE, including major amputation
Endpoint domain: Mortality/survival
Primary endpoint: Successful trials (>= 50% pain relief)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence rate of nasotracheal tube-related pressure injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Median survival times of nasal skin integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cumulative incidence of atopic dermatitis (AD)
Endpoint domain: Mortality/survival
Primary endpoint: AD severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: WAT-1 trend
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: needle redirection frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total consumption of morphine equivalents
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: conceptual knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Remission rates
Endpoint domain: Adverse events/effects
Primary endpoint: PSP scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complication rate (dehiscence, fistula, meatal stenosis)
Endpoint domain: Adverse events/effects
Primary endpoint: Penumbral tissue consumption based on Tmax >6 s
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penumbral tissue consumption based on Tmax >10 s
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall breathing discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean %EWL at 7 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DSQoL total score at 7 years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: clinical worsening
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the curve (AUC) for the EGC index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cartilage denuded
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tibiotalar tilt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DWIHL prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean number of DWIHLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: percentage loss at the labial plate and coronal part of the sockets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean polyethylene wear in the proximal direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in olfaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Declining viral loads
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HDD reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TAC reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EDE Global scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative weight gain during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence rate after treatment of large hiatal hernias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: sustained reduction in menstrual blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in noninvasive TFBUT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in OSDI score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in axillary temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Entry into the hypotympanum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ischaemic events (cardiovascular death, stroke, or myocardial infarction)
Endpoint domain: Mortality/survival
Primary endpoint: total procedural time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: arm symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ΔΕ values of the peri-implant mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction (VAS scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of gestational diabetes mellitus (GDM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Weight gain during gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 30-day risk of death from any cause
Endpoint domain: Mortality/survival
Primary endpoint: Self-efficacy for advanced HA handling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HA satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HA use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time spent in sedentary behavior (SB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprocedural complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Fitzgibbon patency scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean intimal hyperplasia area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean intimal hyperplasia thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of NREM 2 sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage of NREM 3 sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage of REM sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage of NREM 1 sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: median duration of continuous behavioral disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median frequency of discontinuous behavioral disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of GERD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: wrap transmigration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increases in anti-Aβ immunoglobulin G titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Poor neurologic outcome at 180 days
Endpoint domain: Mortality/survival
Primary endpoint: Adherence to methotrexate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction at 3 months post-surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: albuminuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: respiratory arousal index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: JCMA time-related to respiratory arousal index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: microfilariae clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Odds of reoperation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Bayesian AUC48-72
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bayesian AUC72-96
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stent-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Desensitizing effect of biomimetic zinc-hydroxyapatite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative efficacy of OCT-guided versus IVUS-guided PCI strategies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: safety of OCT-guided versus IVUS-guided PCI strategies
Endpoint domain: Adverse events/effects
Primary endpoint: maximum cumulative tolerated dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DBPCFC reaction severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance score
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: arousal reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sleep difficulties reduction
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: lip position change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: upper vermillion lip thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Acceptability Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of scheduled-to-completed sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in symptoms of contact dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mucoperiosteal flap viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Risk of All-Cause Mortality (ACM)
Endpoint domain: Mortality/survival
Primary endpoint: Stress score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hot flash and night sweats frequency and severity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for hot flashes and night sweats
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHIIRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28 day all-cause mortality (ACM)
Endpoint domain: Mortality/survival
Primary endpoint: microbiological eradication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of newborns with SGA
Endpoint domain: Mortality/survival
Primary endpoint: difficulty of swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intensity of sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timing of molecular test conversion from positive to negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical distribution of fixations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Search time for finding the gabor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polysubstance use patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moisture improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: less erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: less scaling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Odds of response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for injection of rescue analgesic
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean agitation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremity motor functions improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher global rating score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: reduced procedural time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher overall satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: satisfaction with pharmacist care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: satisfaction with technician care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bioequivalence of macitentan and tadalafil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Dementia Rating‐Sum of Boxes (CDR‐SB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction of fibrin in the wound bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: intrapulmonary shunt (Qs/Qt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: oxygenation index (OI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: arterial carbon dioxide partial pressure (PaCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Odds of multiple sclerosis (MS) associated with childhood BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate on the restorative level
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: perceived patient-physician interaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PFC rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to PFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative 7-day CFB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year recurrence-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Likelihood of opioid relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Premature study drug discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of VTEs
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of Baveno VI criteria for exclusion of HRV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient anxiety levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional stress of family members
Endpoint domain: Adverse events/effects
Primary endpoint: care burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: WCRF/AICR adherence scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: walking/running
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of steps recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGA-OA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: fear and anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean recession height reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Keratinized tissue height and thickness gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregivers' perceptions of communication with hospice providers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Performance in clinical setting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in FD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rate at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of time with oxygen saturation < 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: success rate of nasal surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean percent change in UPCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sedation during daytime
Endpoint domain: Adverse events/effects
Primary endpoint: blood d-ß-hydroxybutyrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: adequate bowel cleanliness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: willingness to repeat
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: tolerability
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Masticatory function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight of the obturators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postmeal glycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: premeal appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: meal intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: back performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion achieving POEM scores <3
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion achieving ≥4‐point improvement from baseline in NTIS severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion achieving ≥4‐point improvement from baseline in DLQI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average drainage time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complete spontaneous bowel movement (CSBM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient Assessment of Constipation Quality of Life (PAC‐QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient Assessment of Constipation Symptoms (PAC‐SYM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MALE plus POD at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes